Jacobs Levy Equity Management
HAE icon

Jacobs Levy Equity Management’s Haemonetics HAE Stock Holding History

Jacobs Levy Equity Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-177,460
Closed -$15.1M – 1003
2023
Q2 		$15.1M Sell
177,460
-10,423
-6% -$881K 0.09% 232
2023
Q1 		$15.5M Sell
187,883
-55,240
-23% -$4.47M 0.1% 223
2022
Q4 		$19.1M Sell
243,123
-9,682
-4% -$778K 0.13% 198
2022
Q3 		$18.7M Sell
252,805
-20,477
-7% -$1.47M 0.15% 175
2022
Q2 		$17.8M Buy
273,282
+251,253
+1,141% +$14.9M 0.14% 184
2022
Q1 		$1.39M Buy
+22,029
New +$1.2M 0.01% 700
2020
Q1 		– Sell
-5,130
Closed -$589K – 1038
2019
Q4 		$589K Sell
5,130
-1,730
-25% -$209K 0.01% 765
2019
Q3 		$865K Buy
6,860
+2,200
+47% +$279K 0.01% 635
2019
Q2 		$561K Buy
4,660
+1,460
+46% +$144K 0.01% 724
2019
Q1 		$280K Sell
3,200
-4,081
-56% -$371K ﹤0.01% 847
2018
Q4 		$728K Sell
7,281
-920
-11% -$96.6K 0.01% 666
2018
Q3 		$940K Sell
8,201
-47,500
-85% -$4.92M 0.01% 658
2018
Q2 		$5M Sell
55,701
-3,170
-5% -$268K 0.08% 305
2018
Q1 		$4.31M Buy
58,871
+53,011
+905% +$3.64M 0.07% 310
2017
Q4 		$340K Hold
5,860
– – 0.01% 831
2017
Q3 		$263K Buy
+5,860
New +$243K 0.01% 813
2016
Q3 		– Sell
-16,550
Closed -$480K – 1059
2016
Q2 		$480K Sell
16,550
-2,662
-14% -$80.5K 0.01% 768
2016
Q1 		$672K Sell
19,212
-15,900
-45% -$514K 0.01% 659
2015
Q4 		$1.13M Buy
35,112
+880
+3% +$28.5K 0.02% 428
2015
Q3 		$1.11M Buy
+34,232
New +$1.29M 0.02% 467

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Jacobs Levy Equity Management's HAE Position: Q3 2023 in Review

Jacobs Levy Equity Management sold out of Haemonetics (HAE) in Q3 2023, closing a stake of 177,460 shares — an estimated $15.1M sold.

Jacobs Levy Equity Management first reported a position in HAE in Q3 2015 and held it in 20 quarters. The position peaked at $19.1M in Q4 2022. 296 funds tracked by Wall St. Rank hold HAE as of Q3 2023.

  • Jacobs Levy Equity Management reported no remaining Haemonetics position as of Q3 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 177,460 Haemonetics shares in Q3 2023, an estimated $15.1M.
  • Jacobs Levy Equity Management first reported a position in Haemonetics in Q3 2015 and held it in 20 quarters.
  • Jacobs Levy Equity Management's Haemonetics position peaked at $19.1M in Q4 2022.
  • 296 funds tracked by Wall St. Rank held Haemonetics as of Q3 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.